Vaccines against an infection with Bovine Viral Diarrhea Virus/Mucosal Disease (BVD/MD): A short overview;Impfstoffe zum schutz gegen eine infektion mit dem Virus der Bovinen Virusdiarrhoe/Mucosal Disease (BVD/MD): Eine kurze übersicht

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 116, Issue 5-6, 2003, Pages 252-258

  Beer, Martin ^a   Wolf, Georg ^b  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bovine Virus Diarrhea Mucosal Disease (BVD MD); Inactivated vaccine; Modified live vaccine; Vaccine

Indexed keywords

LIVE VACCINE; VIRUS VACCINE;

ANIMAL; CATTLE; CATTLE DISEASE; DRUG DESIGN; GERMANY; IMMUNOLOGY; REPRODUCIBILITY; REVIEW; SAFETY;

ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DRUG DESIGN; GERMANY; REPRODUCIBILITY OF RESULTS; SAFETY; VACCINES, ATTENUATED; VIRAL VACCINES;

ANIMALIA; BOS TAURUS; BOVINAE; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 0037691714     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Becher P., Orlich M., Thiel H. J. (2001): RNA recombination between persisting pestivirus and a vaccine strain: generation of cytopathogenic virus and induction of lethal disease. J. Virol., 75, 6256-6264.
2. Beer, M., Wolf, G., Pichler, J., Wolfmeyer, A., Kaaden, O. R. (1997): Cytotoxic T-lymphocyte responses in cattle infected with bovine viral diarrhea virus. Vet. Microbiol. 58, 9-22.
3. Beer, M., Wolf, G. (1999): Selection of BVDV genotype II isolates using a monoclonal antibody and FACS analysis. Berl. Münch. Tierärztl. Wschr. 112, 345-350.
4. Beer, M., Hehnen, H., Wolfmeyer, A., Poll, G., Kaaden, O.-R., Wolf, G. (2000): A new inactivated BVDV Genotype I and II vaccine: An Immunisation and Challenge Study with BVDV Genotype I. Vet. Microbiol. 77, 195-208.
5. Bielefeldt, O. H. (1995): The pathologies of bovine viral diarrhea virus infection. A window on the pathogenesis. Vet. Clin. North Am. Food Anim. Pract. 11, 447-476.
6. Bolin, S. R. (1995): Control of bovine viral diarrhea infection by use of vaccination. Vet. Clin. North Am. Food Anim. Pract. 11, 615-625.
7. Bolin, S. R., Ridpath, J. F. (1996): Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease. Arch. Virol. 141, 1463-1477.
8. Brownlie, J., Clarke, M. C., Hooper, L. B., Bell, G. D. (1995): Protection of the bovine fetus from bovine viral diarrhoea virus by means of a new inactivated vaccine. Vet. Rec. 137, 58-62.
9. Bruschke, C. J., van Oirschot, J. T., van Rijn, P. A. (1999): An experimental multivalent bovine virus diarrhea virus E2 subunit vaccine and two experimental conventionally inactivated vaccines induce partial fetal protection in sheep. Vaccine 17, 1983-1991.
10. Campos, M., Rossi, C. R., Lawman, M. J. (1982): Natural cell-mediated cytotoxicity of bovine mononuclear cells against virus-infected cells. Infect. Immun. 36, 1054-1059.
11. Chapek, M. L., McClaughry, L. E. und Wilkins, L. M. (1978): Evaluation of a bovine virus diarrhea vaccine. Mod. Vet. Pract. 59, 755-757.
12. Cortese, V. S., Grooms, D. L., Ellis, J., Bolin, S. R., Ridpath, J. F., Brock, K. V. (1998a): Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine. Am. J. Vet. Res. 59, 1409-1413.
13. Cortese, V. S., Whittaker, R., Ellis, J., Ridpath, J. F., Bolin, S. R. (1998b): Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea. Am. J. Vet. Res. 59, 848-850.
14. Dean, H. J., Leyh, R. (1999): Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge. Vaccine 17, 1117-1124.
15. Donis, R. O., Corapi, W., Dubovi, E. J. (1988): Neutralizing monoclonal antibodies to bovine viral diarrhoea virus bind to the 56K to 58K glycoprotein. J. Gen. Virol. 69, 77-86.
16. Fernelius, A. L., Classick, L. G., Smith, R. L. (1971): Evaluation of a soluble antigen vaccine prepared from bovine viral diarrhea-mucosal diseases virus-infected cell cultures. Am. J. Vet. Res. 32, 1963-1979.
17. Fray M. D., Paton D. J., Alenius S. (2000): The effects of bovine viral. diarrhoea virus on cattle reproduction in relation to disease control. Anim. Reprod. Sci., 615-627.
18. Frey, H. R., Eicken, K. (1995): Use of an inactivated bovine viral diarrhoea vaccine to enhance the safety of immunization with live BVD vaccine. Tierärztl. Umschau. 50, 89-93.
19. Frey H. R., Eicken K., Grummer B., Kenklies S., Oguzoglu T. C., Moennig V. (2002): Foetal Protection against Bovine Virus Diarrhoea Virus after Two-step Vaccination. J. Vet. Med. B Infect. Dis. Vet. Public Health 49, 489-493.
20. Grummer B., Beer M., Liebler-Tenorio E., Greiser-Wilke I. (2001): Localization of viral proteins in cells infected with bovine viral diarrhoea virus. J. Gen. Virol., 82, 2597-605.
21. Haralambiev, H., Tsvetkov, P., Nikolov, A., Gaytandgieva, R. (1975): Immunization against mucosal disease-bovine viral Diarrhea (MD-BVD) in calves applying lapinized vaccine against swine fever and a modified live virus of MD-BVD. Arch. Exp. Veterinarmed. 29, 701-704.
22. Harpin, S., Talbot, B., Mbikay, M., Elazhary, Y. (1997): Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2). FEMS Microbiol. Lett. 146, 229-234.
23. Harpin, S., Hurley, D. J., Mbikay, M., Talbot, B., Elazhary, Y. (1999): Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2. J. Gen. Virol. 80, 3137-3144.
24. Hoffman, M. (1999): Risikoabschätzung für den Einsatz der BVD-Lebendvakzine Oregon C24V nach vorheriger Applikation einer Vakzine aus inaktiviertem BVD-Virus: Laborinfektion und Feldversuch an Rindern. Diss. Vet. Med. München.
25. Howard, C. J., Clarke, M. C., Sopp, P., Brownlie, J. (1994): Systemic vaccination with inactivated bovine virus diarrhoea virus protects against respiratory challenge. Vet. Microbiol. 42, 171-179.
26. Kamstrup, S., Ronsholt, L., Jensen, M. H. und Dalsgaard, K. (1992): A novel subunit ISCOM vaccine against bovine virus diarrhoea virus. Rev. Sci. Tech. 11, 873-877.
27. Kamstrup, S., Roensholt, L., Jensen, M. H., Dalsgaard, K. (1999): Production of a highly immunogenic subunit ISCOM vaccine against Bovine Viral Diarrhea Virus. Vaccine 17, 1057-1064.
28. Kweon, C. H., Kang, S. W., Choi, E. J., Kang, Y. B. (1999). Bovine herpes virus expressing envelope protein (E2) of bovine viral diarrhea virus as a vaccine candidate. J. Vet. Med. Sci. 61, 395-401.
29. th day of gestation). Zentralbl. Veterinärmed. B. 31, 669-681.
30. Liess, B., Frey, H. R., Trautwein, G., Peters, W. (1987a): Incidence of persistent bovine diarrhoea virus infection and its effects on the cattle population. Dtsch. Tierärztl. Wschr. 94, 583-585.
31. Liess, B., Orban, S., Frey, H. R., Trautwein, G. (1987b): Consequences of transplacental transmission of bovine diarrhoea virus on bovine fetuses. Dtsch. Tierärztl. Wschr. 94, 585-587.
32. Lobmann, M., Charlier, P., Klaassen, C. L., Zygraich, N. (1986): Safety of a temperature-sensitive vaccine strain of bovine viral diarrhea virus in pregnant cows. Am. J. Vet. Res. 47, 557-560.
33. Makoschey B., Janssen M. G., Vrijenhoek M. P., Korsten J. H., Marel P. (2001): An inactivated bovine virus diarrhoea virus (BVDV) type 1 vaccine affords clinical protection against BVDV type 2. Vaccine, 19, 3261-3268.
34. McClurkin, A. W., Coria, M. F. (1980): Bovine viral diarrhea virus (BVDV) serotiters stimulated in cattle in isolation and under field conditions by inactivated BVDV vaccine. Proc. Annu. Meet. U. S. Anim. Health Assoc. 84, 223-231.
35. Moennig, V., Liess, B. (1995): Pathogenesis of intrauterine infections with bovine viral diarrhea virus. Vet. Clin. North Am. Food Anim. Pract. 11, 477-487.
36. Potgieter, L. N. (1995): Immunology of bovine viral diarrhea virus. Vet. Clin. North Am. Food Anim. Pract. 11, 501-520.
37. Ridpath, J. F., Bolin, S. R., Dubovi, E. J. (1994): Segregation of bovine viral diarrhea virus into genotypes. Virol. 205, 66-74.
38. Schmitt, J., Becher, P., Thiel, H. J., Keil, G. M. (1999): Expression of bovine viral diarrhoea virus glycoprotein E2 by bovine herpesvirus-1 from a synthetic ORF and incorporation of E2 into recombinant virions. J. Gen. Virol. 80, 2839-2848.
39. Stegeman, J. A., Tielen, M. J., Kimman, T. G., van Oirschot, J. T., Hunneman, W. A. Berndsen, F. W. (1994): Intensive regional vaccination with a gI-deleted vaccine markedly reduces pseudorabies virus infections. Vaccine 12, 527-531.
40. Strobe, W., Auer, S., Block, W., Heinen, E., Kretzdorn, D., Rodenbach, C., Schmeer, N. (1996): A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs. Vet. Microbiol. 53, 181-189.
41. Thierauf, P. (1993): Untersuchungen zur Epidemiologie, Diagnose und Immunprophylaxe von BVD/MD-Virusinfektionen in Milchviehzuchtbeständen. Diss. Vet. Med. München.
42. Thomas, P. C., Jones, R. H. (1985): Duration of immunity afforded by one dose of killed-virus bovine viral diarrhea vaccine. Agri. Practice 6, 34-37.
43. van Oirschot, J. T. (1999): Diva vaccines that reduce virus transmission. J. Biotechnol. 73, 195-205.
44. van Oirschot, J. T., Bruschke, C. J., van Rijn, P. A. (1999): Vaccination of cattle against bovine viral diarrhoea. Vet. Microbiol. 64, 169-183.
45. Weiland, E., Stark, R., Haas, B., Rümenapf, T., Meyers, G., Thiel, H. J. (1990): Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer. J. Virol. 64, 3563-3569.
46. Wolf, G., Thierauf, P., Wolfmeyer, A., Beer, M., Pichler, J., Kaaden, O. R. (1996): Impfindikation und Impstrategie bei BVD. Prakt. Tierarzt 77, 4-8.
47. Wolf, G. (1997): BVD/MD als Herdenproblem. Integrierte Tierärztliche Bestandsbetreuung. ITB-Schriftenreihe. Hieronymus, München. 87-98.
48. Wolfmeyer, A., Wolf, G., Beer, M., Strobe, W., Hehnen, H. R., Schmeer, N., Kaaden, O. R. (1997): Genomic (5′UTR) and sero-logical differences among German BVDV field isolates. Arch. Virol. 142, 2049-2057.
49. th World Congress on Diseases of Cattle, Edingburgh. 217-220.
50. Zinkernagel, R. M. (1994). Some general aspects of immunity to viruses. Vaccine 12, 1493-1494.